Fibrosis News and Research

RSS

Fibrosis is the growth of fibrous tissue.

Scientists create living phlegm replica to study cystic fibrosis infections

Scientists have engineered a living material resembling human phlegm, which will help them to better understand how a certain kind of infection develops on the lungs of patients with cystic fibrosis.

21 Nov 2023

Pitt researcher receives $1.95 million grant to study cell communication

Day by day, we communicate with our office colleagues to accomplish tasks that are necessary to function.

21 Nov 2023

Amalus Therapeutics develops innovative approach for treating patients with cancer or fibrotic diseases

Ghent University and the booming Ghent biotech landscape welcome a brand new spin-off: Amalus Therapeutics is developing a new class of drugs that selectively target corrupt fibroblast cells.

20 Nov 2023

MHRA extends the license of two cystic fibrosis drugs for children aged two to five years old

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (15 November 2023) extended the licence of the cystic fibrosis medicines Kaftrio (ivacaftor, tezacaftor and elexacaftor) and Kalydeco (ivacaftor) for children aged two to five years old.

20 Nov 2023

Intestinal hormones hold promise for halting liver scarring

Hormone therapy may be associated with menopause and fertility treatment, but now an SDU-led research team reports that certain intestinal hormones seem to have a beneficial effect on the processes behind the formation of scar tissue in the liver (liver fibrosis).

16 Nov 2023

Researchers discover genetic mechanism behind pancreatic cancer metastasis

Pancreatic cancer is tricky to manage because it spreads easily and early, and the tumors have a unique biological makeup.

15 Nov 2023

COVID-19 triggers epigenetic alterations that drive lung damage and fatalities

The COVID-19 disease, due to infection with the SARS-CoV2 virus, became an international pandemic in 2020. To date, more than 770 million people have suffered from the disease and nearly 7 million of them have lost their life.

14 Nov 2023

Is obesity an independent risk factor for cardiovascular disease?

Researchers explore how obesity contributes to cardiovascular disease by investigating this association in low-risk people.

10 Nov 2023

New insights into the pathogenesis of chronic liver diseases

Fatty liver diseases (FLD) have become a significant health concern worldwide, affecting millions. The two most common types of FLD are non-alcoholic fatty liver disease (NAFLD) and alcoholic-associated liver disease (ALD). NAFLD is associated with obesity, insulin resistance, and metabolic syndrome, while ALD is caused by excessive alcohol consumption.

7 Nov 2023

Surgeons to get a high-tech assistant: Smartphone app for assessing liver surgery risks

Researchers developed a multivariable model to predict clinically relevant posthepatectomy liver failure grade B and C, grade C, and 90-day mortality prediction.

6 Nov 2023

States reconsider religious exemptions for vaccinations in child care

More than half the children who attend Munchkin Land Daycare near Billings, Montana, have special needs or compromised immune systems.

3 Nov 2023

Shark skin mucus shows potential for biomedical applications

Sharks differ from other fish in many ways, including an apparently remarkable ability to heal from wounds, according to reports of sharks recovering from injuries sustained in the wild.

2 Nov 2023

Unbiased proteomic analysis reveals fibroinflammatory landscape of the aging ovary

A new priority research paper was published on the cover of Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 20, entitled, "Proteomic quantification of native and ECM-enriched mouse ovaries reveals an age-dependent fibro-inflammatory signature."

31 Oct 2023

From Mount Everest to your liver: The alarming reach of 'forever chemicals' in our environment and health

Research paper provides a comprehensive review of per- and polyfluoroalkyl substances (PFAS), exploring their environmental prevalence, human exposure risks, and liver toxicity. The study highlights urgent gaps in PFAS research and calls for more studies to better understand these 'forever chemicals' and their impact on human health.

26 Oct 2023

Researchers identify mechanism through which dietary omega 3 supplements alleviate liver condition

A study spearheaded by Oregon State University has shown why certain polyunsaturated fatty acids work to combat a dangerous liver condition, opening a new avenue of drug research for a disease that currently has no FDA-approved medications.

25 Oct 2023

Eating ultra-processed foods puts your liver at risk, new study warns

Research found a significant link between the consumption of ultra-processed foods (UPFs) and increased risks of non-alcoholic fatty liver disease, liver cirrhosis, and severe hepatic illnesses. The findings suggest that reducing UPF intake could be key to enhancing liver health and well-being.

25 Oct 2023

Red grape polyphenol, resveratrol: a multifaceted therapeutic powerhouse under review

The therapeutic potential of resveratrol, a red grape polyphenol.

25 Oct 2023

Study reveals unexpected role of pulmonary ionocytes in lung function

A new study by University of Iowa researchers finds that rare lung cells known as pulmonary ionocytes facilitate the absorption of water and salt from the airway surface.

24 Oct 2023

Pioneering partnership supports early-stage innovation against antimicrobial resistance to save lives

Innovate UK, LifeArc, and Medicines Discovery Catapult (MDC) have joined forces to create PACE (Pathways to Antimicrobial Clinical Efficacy), a £30 million initiative supporting early-stage innovation against antimicrobial resistance (AMR) to save lives. PACE has today (19 October 2023) announced its first funding call with up to £10 million available to support innovators developing new antimicrobials.

20 Oct 2023

Major study wins €5.6M funding to build a better understanding of cystic fibrosis in children

A major new study led by RCSI University of Medicine and Health Sciences and Children's Health Ireland (CHI) has been awarded funding of €5.6M to work with babies and children in Ireland and the UK over the next five years to build a better understanding of cystic fibrosis.

18 Oct 2023

Fibrosis News and Research

Further Reading

Scientists create living phlegm replica to study cystic fibrosis infections

Pitt researcher receives $1.95 million grant to study cell communication

Amalus Therapeutics develops innovative approach for treating patients with cancer or fibrotic diseases

MHRA extends the license of two cystic fibrosis drugs for children aged two to five years old

Intestinal hormones hold promise for halting liver scarring

Researchers discover genetic mechanism behind pancreatic cancer metastasis

COVID-19 triggers epigenetic alterations that drive lung damage and fatalities

Is obesity an independent risk factor for cardiovascular disease?

New insights into the pathogenesis of chronic liver diseases

Surgeons to get a high-tech assistant: Smartphone app for assessing liver surgery risks

States reconsider religious exemptions for vaccinations in child care

Shark skin mucus shows potential for biomedical applications

Unbiased proteomic analysis reveals fibroinflammatory landscape of the aging ovary

From Mount Everest to your liver: The alarming reach of 'forever chemicals' in our environment and health

Researchers identify mechanism through which dietary omega 3 supplements alleviate liver condition

Eating ultra-processed foods puts your liver at risk, new study warns

Red grape polyphenol, resveratrol: a multifaceted therapeutic powerhouse under review

Study reveals unexpected role of pulmonary ionocytes in lung function

Pioneering partnership supports early-stage innovation against antimicrobial resistance to save lives

Major study wins €5.6M funding to build a better understanding of cystic fibrosis in children

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News